A highly sensitive ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method was developed for the quantification of vancomycin (VAN) in low volumes of rabbit serum. For each analysis, 2 µL of rabbit serum was precipitated with methanol that contained the internal standard teicoplanin (TEI). The supernatant was transferred into a 384 well-plate, diluted with water, covered with a pierceable silicone mat and 5 µL was analyzed in positive ionization mode. The UHPLC-MS/MS consisted of an Agilent 1290 Infinity UHPLC system connected to an AB Sciex QTrap ® 5500 hybrid linear ion-trap triple quadrupole mass spectrometer equipped with a Turbo Spray source. Chromatographic separation was achieved using a Waters Acquity UPLC BEH C 18 (1.7 µm, 2.1 mm × 100 mm) column, a Van-Guard (1.7 µm, 2.1 × 5 mm) guard column and a mobile phase of water and methanol both containing 5 mM ammonium acetate with 0.1% formic acid. VAN was quantified with multiple reaction monitoring using the transitions of m/z 725.5/144.2, and TEI was monitored at m/z 940.6/316.4. The accuracy, precision, linearity, range and lower limit of quantification (LLOQ) were determined. The accuracy was ≤9.93% and the precision was ≤10.6%. The range was established as 0.1 to 40 µg•mL −1 . The LLOQ was 0.1 µg•mL −1 VAN requiring 2 µL of sample with an accuracy of −20.2% and precision of 8.39%. The method was applied successfully to determine the VAN concentrations in rabbit serum after the i.v. administration of VAN.
Introduction
Vancomycin (VAN) is a glycopeptide antibiotic used to treat severe bacterial infections caused by, for example, methicillin-resistant Staphylococcus aureus. If VAN is not dosed properly, it can cause drug resistance, kidney damage, and hearing loss in patients [1] [2] . In the clinical practice, the dosage regimen of VAN is personalized using therapeutic drug monitoring (TDM) and the blood concentration of the drug is monitored closely using an appropriate analytical technique [1] [2] .
There are several methodologies available for the measurements of VAN in biological matrices that include radioimmunoassays, fluorescence immunoassays, fluorescence polarization immunoassays [3] , particle enhanced turbidimetric inhibition immunoassays (PETINIA) [4] , liquid chromatography (LC) [5] , and LC-tandem mass spectrometry (LC-MS/MS) [6] [7] [8] [9] . These methods were successfully used to measure VAN in a variety of matrices, but they had their limitations. They either were not sufficiently precise [3] , suffered from interference [4] , had insufficient sensitivity [5] [6] [8] , or required large sample volumes [6] [8] [7] [9] . Large sample volumes are sometimes difficult to obtain, especially in studies where VAN is determined in the samples of small laboratory animals, such as rabbits, where the availability of the biological matrix is limited.
There are assays available in the literature to determine VAN in rabbit serum [10] [11] ; however, there have been no attempts to quantify VAN in rabbit serum using LC-MS/MS. The objective of this study was to develop a sensitive and selective ultra-high performance LC-MS/MS (UHPLC-MS/MS) method for the quantification of trace levels of VAN in rabbit serum requiring a low sample volume. The method was applied successfully to measure the VAN concentrations in rabbit serum after the i.v. administration of VAN. The data were compared to results obtained by PETINIA in a previous study (unpublished data). To our knowledge, this is the first UHPLC-MS/MS assay for the quantitation of trace levels of VAN in rabbit serum requiring only 2 µL of sample. The feasibility was investigated to expand the current assay to larger studies in the future where the method is modified and implemented in similar matrices, such as interstitial fluid (ISF) [12] . 
Experimental

Materials and Reagents
Rabbit Experiments
Animal experiments conducted in this study were approved by The University of British Columbia Animal Care Committee (Certificate number A10-0149) and
adhered to the guide for the care and use of experimental animals [13] . New 
Instrumentation and Chromatographic Conditions
The UHPLC-MS guard column. The columns were maintained at 35˚C and the autosampler tray temperature was maintained at 10˚C. Solvent A was water with 5 mM ammonium acetate (AA) and 0.1% formic acid (FA), and solvent B was methanol with 5 mM AA and 0.1% FA. The mobile phase initial conditions were solvent A (95%) and solvent B (5%) that was ramped to solvent A (5%) by 0.80 min held until 4.0 min and followed by an equilibration with solvent A (95%) and solvent B (5%) for 2 min. The flow rate was 0.2 mL•min −1 , the injection volume was 5 µL with a total run time of 6.0 min. Samples were injected from a 384-well plate. American Journal of Analytical Chemistry
Mass Spectrometric Parameters
The mass spectrometer was operated in multiple reaction monitoring (MRM) mode with the mass spectrometric parameters as follows. Curtain gas, 30 psi, collision gas (CAD), high, ionspray, 5500 V, temperature, 450˚C, ion source gas 1, 30 psi, ion source gas 2, 40 psi. Nitrogen gas was used for curtain gas, collision gas, ion source gas 2 (vaporizing gas), and zero air was used for ion source gas 1 (nebulizing gas). Entrance potential was 10 V, resolution was Unit for Q1, Q3, and dwell time was 150 msec for the compounds. 
MRM Experiments
Preparation of Calibration Standards and Quality Controls
Sample Preparation
Ten µL of ice-cold precipitation reagent containing the 600 ng•mL −1 IS was pipetted into 0.5 mL tubes (Eppendorf, lowBind, Mississauga, ON, Canada) on ice.
After adding 2 µL of calibration standards, QC samples, or study serum sample, 
Linearity and Range
Calibration curves were prepared on separate days (n = 3) as detailed in section 
Results and Discussion
Mass Spectrometry, Liquid Chromatography
The precursor ions and the product ions of VAN 
Method Qualification
Accuracy and Precision
The results for accuracy and precision of VAN are presented in Table 1 . Intraand inter-day accuracy ranged between 2.11% and 9.93%, and between 5.07% and 7.44%, respectively. Intra-and inter-day precision ranged between 2.51% and 10.6%, and between 6.46% and 8.94%, respectively. The method was accurate and precise for the QC-Low, QC-Mid, and QC-High samples with a %Deviation ± 15% and %RSD ≤ 15%, respectively.
LLOQ, Linearity and Range
The LLOQ was determined in five replicate samples at a concentration of serum is presented in the inset of Figure 1 . The linear range of the assay was established as 0.1 to 40 µg•mL −1 with the regression coefficient (mean ± SD, n = 3) r = 0.99 ± 0.003. This met the acceptance criterion for linearity of r ≥ 0.98 after weighting with 1/x 2 . Calibration curves were evaluated without weighting, and with a weighting factor of 1/x and 1/x 2 . The weighting factor of 1/x 2 was used in the present study, because it provided the lowest variance of the calibration points, particularly at the LLOQ and it was the simplest model to adequately describe the curve [14] . Furthermore, this weighting factor is often used for bioanalytical assays using LC/MS/MS [15] .
VAN Pharmacokinetics in Rabbits
The developed method was successfully applied to measure serum VAN levels after the i.v. administration of five doses of VAN to rabbits (n = 5). The concen- 
Applicability for Future Studies
The present study reports a novel UHPLC-MS/MS method that is quick, sensitive, accurate and precise for the quantitation of VAN requiring only 2 µL of sample. The matrix used was rabbit serum, but the method may be easily transferable to other matrices, such as dried blood spots or ISF where only low sample volumes are available. The applicability of the method in ISF would be particularly useful, because once the method is transferred and fully validated in ISF, it can be implemented in studies, such as TDM of VAN in ISF [12] . One shortcoming of the present study may be noted as the method was qualified, not fully validated. However, a full validation was not the aim of the current pilot study, but to qualify the method and apply it for PK studies in rabbits. The significance of the current study is that the method qualification results obtained may provide useful information to assess the feasibility of expanding the process to larger studies in the future where the method is fully validated in appropriate matrices, such as ISF, and implement it in studies on TDM of VAN in ISF.
Conclusion
A sensitive and selective UHPLC-MS/MS method was developed for the quantification of VAN in rabbit serum requiring 2 µL of sample. The assay was applied for the measurement of VAN in serum samples of rabbits after the i.v. administration of VAN. The results were compared to data previously acquired using PETINIA. The current UHPLC-MS/MS method is superior to the PETINIA technique as it requires only 2 µL of sample compared to the large volumes (50 µL to fill the sample cuvette) required by the immunoassay. Other LC-MS/MS assays determined VAN in human [8] or rat plasma [7] , and human serum [6] .
While some of these assays achieved good sensitivity, they required large sample volumes and none of them attempted to measure VAN in rabbit serum [2] [7] [16] . Other methods determined VAN in rabbit serum, but the sensitivity of these assays was insufficient [10] [11] . Compared to these assays, the current method has good sensitivity and to our knowledge, it is the first UHPLC-MS/MS method to quantify VAN in rabbit serum using only 2 µL of sample. The method may be easily transferable to other matrices, such as dried blood spots or ISF where obtaining VAN for TDM is only possible in very small volumes [12] .
In fact, many experiments involving small laboratory animals, such as rabbits, will benefit from this method that allows for repeated sampling of very small biological samples.
